Safety and Tolerability Study of N6022 in Healthy Subjects

NCT01147406 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: N6022
DRUG: Placebo

Sponsor

Nivalis Therapeutics, Inc.